磷酸化成视网膜细胞瘤抑癌蛋白抗体

英文名称    phospho-Rb (Ser780)    

中文名称    磷酸化成视网膜细胞瘤抑癌蛋白抗体    

别    名    Rb(Phospho-Ser780); p105-Rb (phospho-Ser780); p105-Rb (phospho Ser780); p-Rb (Ser780); OSRC; P105 RB; P105RB; PP105; PP110; pRb; RB 1; RB1; RB1 protein; Retinoblastoma 1 (including osteosarcoma); Retinoblastoma 1; Retinoblastoma associated protein; Including osteosarcoma; Osteosarcoma; p105-Rb; Rb; RB_HUMAN; Retinoblastoma suspectibility protein; Retinoblastoma-associated protein; Retinoblastoma related osteosarcoma; Retinoblastoma susceptibility gene.    

磷酸化成视网膜细胞瘤抑癌蛋白抗体        

说 明 书    0.1ml      

产品类型    磷酸化抗体     

研究领域    肿瘤  细胞生物  免疫学  染色质和核信号  表观遗传学      

抗体来源    Rabbit    

克隆类型    Polyclonal    

交叉反应    Human, Mouse, Rat, Chicken, Dog, Cow,     

产品应用    WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.    

分 子 量    106kDa    

细胞定位    细胞核     

性    状    Lyophilized or Liquid    

浓    度    1mg/1ml    

免 疫 原    KLH conjugated Synthesised phosphopeptide derived from human Rb around the phosphorylation site of (Ser780)    

亚    型    IgG    

纯化方法    affinity purified by Protein A    

储 存 液    0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide    

保存条件    Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.    

磷酸化成视网膜细胞瘤抑癌蛋白抗体产品介绍    background:
The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma.

Function:
Key regulator of entry into cell division that acts as a tumor suppressor. Promotes G0-G1 transition when phosphorylated by CDK3/cyclin-C. Acts as a transcription repressor of E2F1 target genes. The underphosphorylated, active form of RB1 interacts with E2F1 and represses its transcription activity, leading to cell cycle arrest. Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. ecruits and targets histone methyltransferases SUV39H1, SUV420H1 and SUV420H2, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the epressor complex (By similarity). In case of viral infections, interactions with SV40 large T antigen, HPV E7 protein or adenovirus E1A protein induce the disassembly of RB1-E2F1 complex thereby disrupting RB1's activity. 

Subunit:
Interacts with ATAD5. Interacts with PRMT2, CDK1 and CDK2. The hypophosphorylated form interacts with and sequesters the E2F1 transcription factor. Interacts with heterodimeric E2F/DP transcription factor complexes containing TFDP1 and either E2F1, E2F3, E2F4 or E2F5, or TFDP2 and E2F4. The unphosphorylated form interacts with EID1, ARID3B, KDM5A, SUV39H1, MJD2A/JHDM3A and THOC1. Interacts with the N-terminal domain of TAF1. Interacts with AATF, DNMT1, LIN9, LMNA, SUV420H1, SUV420H2, PELP1 and TMPO-alpha. May interact with NDC80. Interacts with GRIP1 and UBR4. Interacts with ARID4A and KDM5B. Interacts with E4F1 and LIMD1. Interacts with SMARCA4/BRG1 AND HDAC1. Interacts with adenovirus E1A protein, HPV E7 protein and SV40 large T antigen. Interacts with PSMA3 and USP4. Interacts (when methylated at Lys-860) with L3MBTL1.

Subcellular Location:
Nucleus.

Tissue Specificity:
Expressed in the retina.

Post-translational modifications:
Phosphorylated by CDK6 and CDK4, and subsequently by CDK2 at Ser-567 in G1, thereby releasing E2F1 which is then able to activate cell growth. Dephosphorylated at the late M phase. SV40 large T antigen, HPV E7 and adenovirus E1A bind to the underphosphorylated, active form of pRb. Phosphorylation at Thr-821 and Thr-826 promotes interaction between the C-terminal domain C and the Pocket domain, and thereby inhibits interactions with heterodimeric E2F/DP transcription factor complexes. Dephosphorylated at Ser-795 by calcineruin upon calcium stimulation. CDK3/cyclin-C-mediated phosphorylation at Ser-807 and Ser-811 is required for G0-G1 transition. Phosphorylated by CDK1 and CDK2 upon TGFB1-mediated apoptosis.
N-terminus is methylated by METTL11A/NTM1. Monomethylated at Lys-860 by SMYD2, promoting interaction with L3MBTL1.

DISEASE:
Defects in RB1 are the cause of childhood cancer retinoblastoma (RB) [MIM:180200]. RB is a congenital malignant tumor that arises from the nuclear layers of the retina. It occurs in about 1:20'000 live births and represents about 2% of childhood malignancies. It is bilateral in about 30% of cases. Although most RB appear sporadically, about 20% are transmitted as an autosomal dominant trait with incomplete penetrance. The diagnosis is usually made before the age of 2 years when strabismus or a gray to yellow reflex from pupil ('cat eye') is investigated. 
Defects in RB1 are a cause of susceptibility to bladder cancer (BLC) [MIM:109800]. A malignancy originating in tissues of the urinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladder cancers are transitional cell carcinomas. They begin in cells that normally make up the inner lining of the bladder. Other types of bladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmental influences. 
Defects in RB1 are a cause of osteogenic sarcoma (OSRC) [MIM:259500].

Similarity:
Belongs to the retinoblastoma protein (RB) family.

Gene ID:
5925

Database links:

Entrez Gene: 5925 Human

Entrez Gene: 19645 Mouse

Entrez Gene: 24708 Rat

Omim: 614041 Human

SwissProt: P06400 Human

SwissProt: P13405 Mouse

SwissProt: P33568 Rat

Unigene: 408528 Human

Unigene: 273862 Mouse

Unigene: 55115 Rat

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.    

磷酸化成视网膜细胞瘤抑癌蛋白抗体

hz-1120R FLIP  凋亡调节基因之一抗体（短型）

hz-2767R FLT-3/CD135  FMS样酪氨酸激酶3

hz-3147R Phospho-FLT3(Tyr591)  磷酸化FMS样酪氨酸激酶3

hz-3149R Phospho-FLT3 (Tyr589/591)  磷酸化FMS样酪氨酸激酶3

hz-3150R Phospho-FLT3 (Tyr842)  磷酸化FMS样酪氨酸激酶3

hz-3151R Phospho-FLT3 (Tyr969)  磷酸化FMS样酪氨酸激酶3

hz-0666R FN/Fibronectin 1  纤维连接蛋白抗体

hz-5945R SnoN  Smad核转录共抑制因子抗体

hz-5946R TNFAIP8  肿瘤坏死因子α诱导蛋白8抗体

hz-5947R TTC23  宫颈癌原癌基因8抗体

hz-1170R FOS B  FosB蛋白抗体

hz-2572R FPR1  甲酸基肽受体1抗体

hz-1154R FRA1/FOSL1  FRA-1蛋白抗体

hz-5948R CIP2A/p90 Autoantigen  蛋白磷酸酶PP2A癌抑制蛋白抗体

hz-3158R Phospho-FRA1(Ser265)  磷酸化FRA-1蛋白抗体

hz-1188R FRA2/FOSL2  FRA2/FOSL2抗体

hz-4950R ERAS/HRAS2  胚胎干细胞RAS蛋白抗体

hz-5125R Frizzled 7/FZE3  卷曲蛋白FZD7抗体

hz-1675R fowl typhoid and pullorum disease  鸡白痢、鸡伤寒抗体

hz-2358R FOXA2/HNF 3beta  肝细胞核因子3抗体

hz-2585R FOXF1  叉头蛋白F1抗体

hz-1775R FOXJ1/HFH-4  叉头蛋白J1抗体

hz-1275R FoxP1  叉头蛋白P1抗体

hz-2687R FOXM1/HFH 11  叉头蛋白M1抗体

hz-5951R LIMS1  整合素和生长因子样蛋白1抗体

hz-0269R FoxP3  叉头蛋白P3抗体

hz-2537R FOXO1  叉头蛋白O1抗体

hz-3137R Phospho-FoxO1(Thr24)/FoxO3a(Thr32)  磷酸化叉头蛋白家族抗体

hz-3141R Phospho-FoxO1 (Ser319)  磷酸化叉头蛋白家族1抗体

hz-3142R Phospho-FoxO1 (Ser256)  磷酸化叉头蛋白家族1抗体

hz-1548R FOXO3A  叉头蛋白O3A抗体

hz-3138R Phospho-FoxO3a (Ser318/321)  磷酸化叉头蛋白3A抗体

hz-3139R Phospho-FoxO3a (Ser294)  磷酸化叉头蛋白3A抗体

hz-3140R Phospho-FoxO3a (Ser253)  磷酸化叉头蛋白3A抗体

hz-2766R FOXO4  叉头蛋白O4抗体

hz-3143R Phospho-FoxO4 (Ser193)  磷酸化叉头蛋白4抗体

hz-3144R phospho-FOXO4 (Ser197)  磷酸化叉头蛋白4抗体